| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.02T | 1.05T | 957.94B | 942.61B | 756.98B |
| Gross Profit | 168.91B | 180.29B | 157.40B | 140.89B | 73.87B |
| EBITDA | 84.17B | 151.99B | 128.71B | 121.25B | 60.48B |
| Net Income | 132.99B | 305.38B | 101.99B | 694.90B | 642.42B |
Balance Sheet | |||||
| Total Assets | 2.34T | 2.21T | 2.11T | 2.05T | 1.57T |
| Cash, Cash Equivalents and Short-Term Investments | 322.55B | 204.72B | 272.62B | 349.43B | 247.34B |
| Total Debt | 296.05B | 344.86B | 287.78B | 351.69B | 416.45B |
| Total Liabilities | 502.00B | 532.60B | 484.83B | 505.93B | 590.07B |
| Stockholders Equity | 1.80T | 1.65T | 1.59T | 1.52T | 884.63B |
Cash Flow | |||||
| Free Cash Flow | 181.26B | 143.46B | 120.13B | 388.41B | 185.32B |
| Operating Cash Flow | 264.77B | 273.17B | 202.45B | 456.05B | 226.46B |
| Investing Cash Flow | -35.11B | -126.13B | -66.33B | -103.62B | -5.85B |
| Financing Cash Flow | -124.75B | -211.65B | -223.18B | -243.91B | -116.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥180.75B | 7.13 | 13.08% | 3.75% | -7.12% | 29.40% | |
72 Outperform | ¥1.58T | 13.73 | 11.32% | 5.12% | -2.82% | -54.04% | |
64 Neutral | ¥2.24T | 11.43 | 10.82% | 6.25% | -6.37% | -52.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥2.12T | 17.02 | 10.90% | 5.81% | 2.80% | -47.61% | |
54 Neutral | ¥159.24B | 17.08 | ― | 4.08% | -10.27% | -16.20% | |
47 Neutral | ¥11.03B | 38.42 | ― | 5.77% | 2.31% | -91.89% |